Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS

Similar documents
COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS

INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS

Diagnose a broad range of metabolic disorders with a single test, Global MAPS

Utility of Microarrays in Molecular Genetics

Mitochondrial Disorders Genetic Testing

BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.

devact TM Clinical Management Panel for Neurodevelopmental Disorders

A. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia

All diseases on Foresight

BabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related

Joshua Hellmann Foundation - Newborn Metabolic Screening Program

For Your Baby s Health Department of Health

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Subject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:

Sema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations

N.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017

MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the

General Test Requisition Form - Biochemical and Molecular

NEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES

Foresight Carrier Screen

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

NEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

Newborn Genetic Analysis

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Evolve FamilyReady Carrier Screen

General Test Requisition Form - Biochemical and Molecular

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

High Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)

NutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:

CHRONIC MYELOGENOUS LEUKEMIA

Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database

Foresight Carrier Screen

PRICE AND TEST LIST January 4, 2018 (by Test Code)

Inborn Errors of Metabolism (IEM)

Further expansion of the neonatal screening panel in the Netherlands

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

PRICE AND TEST LIST August 24, 2018 (by Test Code)

CLINICAL AND HUMAN TESTING

NEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School

MetBioNet Best Practice Guidelines. Investigation of an inherited metabolic cause of cardiomyopathy

Foresight Carrier Screen

Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:

Foresight Carrier Screen

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD

Foresight Carrier Screen

SAMPLE. Carrier Screening Results Report v2.2 Page 1/8

Promo Code (if applicable) mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.

NGS Panel Plus. Sequencing Sequencing + NGS based CNVs Del/Dup with MLPA. Clinic. Department. Street. ZIP Code/Town. Country. . Billing.

Foresight Carrier Screen

Promo Code (if applicable) ... mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.

Title: Assessing Recommendations Related To Timeliness of Newborn Screening

Joshua Hellmann Foundation - Newborn Metabolic Screening Program

Foresight Carrier Screen

Positive Newborn Screens: What do you do next?

theraseek Panel Gene List by Category

HERES Carrier Screening TEST

COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS

LABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS

Newborn Screening: Focus on Treatment

Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:

GUIDE TO NEWBORN SCREENING PROGRAMME

4978 Santa Anita Ave Temple City, CA (p) (f)

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

Cytogenetic Biochemical

Approach to diagnosis of metabolic diseases

TRANSAMINATION AND UREA CYCLE

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

BULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)

Mitochondrial disorders are among the most severe

Clinical Management of Organic Acidemias and OAA Natural History Registry. Kim Chapman MD PhD Children s National Rare Disease Institute

Residual risks by ethnicity

CARRIER SCREEN - LIST OF DISORDERS

Request for expedited Result

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Supplemental Figure 1

Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future?

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

CPT Code and Price List

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

Newborn Screening in Manitoba. Information for Health Care Providers

The Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem

Metabolic Disorders. Chapter Thomson - Wadsworth

LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.

Requisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection:

[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995

ANNUAL REPORT France 11. Italy 5. Spain 5. Portugal 2. Czech Republic 1. Switzerland 1. Total 25

Urea Cycle Disorders and Hyperammonemia: Diagnosable Treatable Screenable

2015 Annual Report for New Mexico s Newborn Screening (NBS) Program

BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona

SUPPLEMENTARY,INFORMATIONS,,,, mtorc1,is,required,for,brown,adipose,tissue,recruitment,and, METABOLIC,ADAPTATION,TO,COLD,!! Sébastien!M.!

Urea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training

Introduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.

Family Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis

Metabolic Muscle Diseases

Comprehensive Molecular Testing for Fatty Acid Oxidation Disorders. A Guide for Clinicians

Expanded carrier screening for monogenic disorders: where are we now?

Transcription:

UNIVERSITY OF MINNESOTA PHYSICIANS OUTREACH LABS MOLECULAR DIAGNOSTICS (612) 273-8445 DATE: TIME COLLECTED: AM PM PCU/CLINIC: DIAGNOSIS (Dx) / DIAGNOSIS CODES (ICD-9) - OUTPATIENTS ONLY (1) (2) SPECIMEN TYPE: o Blood PATIENT IDENTIFICATION (3) (4) PLEASE COLLECT 5-10CC IN ACD-A OR EDTA TUBE ORDERING PHYSICIAN NAME AND PHONE NUMBER: Tests can be ordered as a full panel, or by individual gene(s). Please contact the genetic counselor with any questions at 612-624-8948 or by pager at 612-899-3291. Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS 2- Methyl- 3- hydroxybutyric aciduria 2- Methylbutyryl- CoA dehydrogenase ACADSB 3- Hydroxy 3- methylglutaric aciduria HMGCL 3- hydroxyacyl- CoA dehydrogenase HADH 3- hydroxyisobutryl- CoA hydrolase HIBCH 3- Methylcrotonyl- CoA carboxylase MCCC1 MCCC2 3- methylglutaconic aciduria (other types) II TAZ 3- methylglutaconic aciduria (other types) III OPA3 3- methylglutaconic aciduria (other types) V DNAJC19 3- Methylglutaconic aciduria type I AUH Acatalasemia CAT Acid- labile subunit, of IGFALS Alkaptonuria HGD alpha subunit of the succinate- CoA ligase enzyme (mito depletion w/ methylmalonic acidemia) SUCLA2 Alpha- methylacetoacetic aciduria Aminoacylase 1 ACY1 Arginemia ARG1 Argininosuccinate acidemia ASL ASPARAGINE SYNTHETASE DEFICIENCY ASNS Aspartylglycosaminuria AGA beta subunit of the succinate- CoA ligase enzyme (mito depletion w/ methylmalonic acidemia SUCLG1 Beta- ureidopropionase UPB1 BIOTINIDASE BTD HLCS Calcification of joints and arteries NT5E Canavan disease ASPA Carboxylesterase 1 CES1 Carnitine acetyltransferase Carnitine acylcarnitine translocase SLC25A20 Carnitine palmitoyltransferase CPT1A CPT2 Carnitine uptake defect Cerebral creatine 1 SLC6A8 Chylomicron retention disease SAR1B Submit this form along with the appropriate Molecular requisition (Molecular Diagnostics or Molecular NGS Oncology). Citrullinemia ASS1 SLC25A13 Coenzyme Q10 COQ2 PDSS1 PDSS2 ADCK3 COQ9 COQ6 Combined malonic and methylmalonic aciduria ACSF3 D- 2- hydroxyglutaric aciduria D2HGDH IDH2 D- glyceric aciduria GLYCTK Defects of biopterin cofactor regeneration PCBD1 PTS Deficiency of butyrylcholine esterase BCHE Dienoyl- CoA reductase DECR1 Dihydrolipoamide dehydrogenase DLD Dihydropyrimidine dehydrogenase DPYD Dihydropyrimidinuria DPYS Dimethylglycine dehydrogenase DMGDH

Dopamine beta- hydroxylase DBH DRD BH4 SYNTHESIS SPR Epsilon- trimethyllysine hydroxylase TMLHE Ethylmalonic encephalopathy ETHE1 Familial Hyperinsulinemia ABCC8 KCNJ11 Folate malabsorption, hereditary SLC46A1 Fructose intolerance ALDOB Fructose- 1,6- bidphosphatase FBP1 Galactosemia GALK1 GALE GALT Galactosialidosis CTSA Glutamate formiminotransferase FTCD Glutamine, congenital GLUL Glutaric academia ETFA ETFB ETFDH GCDH Glutathione synthetase GSS Glycerol kinase GK Glycine encephalopathy GCSH GLDC Glycine N- methyltransferase GNMT Glycogen storage disease GYS1 G6PC SLC37A4 GAA AGL GBE1 PHKG2 PHKA1 PYGM PYGL PFKM PGAM2 LDHA ALDOA ENO3 PGM1 GYG1 PHKB GYS2 PHKA2 PIGM Glycosylphosphatidylinositol PIGM Heme oxygenase- 1 HMOX1 Hereditary orotic aciduria UMPS HMG- CoA synthase- 2 HMGCS2 HOMOCYSTEINURIA CBS MTHFR Hypercarotenemia and vitamin A, autosomal dominant BCMO1 Hyperglycinuria SLC6A20 Hyperhomocystinemia - methionine synthase reductae - cble MTRR Hyperhomocystinemia - methionine synthase- cbl G MTR Hyperinsulinism- hyperammonemia GLUD1 Hyperlysinemia AASS Hypermethioninemia due to adenosine kinase ADK Hypermethioninemia with of S- adenosylhomocysteine hydrolase AHCY Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III MAT1A Hyperphe/biopterin metabolism QDPR PCBD1 PAH SPR Hyperoxaluria, primary, type III HOGA1 Hypoglycemia ABCC8 ACAT2 AGL ALDOA ENO3 G6PC GAA GBE1 GYS1 GYS2 KCNJ11 LDHA OXCT1 PFKM PGAM2 PGM1 PHKA1 PHKA2 PHKB PHKG2 PYGL PYGM SLC37A4 hypophosphotasia ALPL Isobutyryl- CoA dehydrogenase ACAD8 ISOVALERIC ACIDEMIA IVD L- 2- hydroxyglutaric aciduria L2HGDH Lactase, congenital LCT Lactate dehydrogenase- B LDHB LCHAD Leukotriene C4 synthase LTC4S

Lysinuric protein intolerance SLC7A7 Malonyl- CoA decarboxylase MLYCD Maple syrup urine disease BCKDHA BCKDHB DBT MCAD ACADM Methylmalonate semialdehyde dehydrogenase ALDH6A1 Methylmalonic acidemia MCEE MMADHC LMBRD1 MUT MMAA MMAB ABCD4 Mevalonic aciduria MVK mitochondrial acetoacetyl- CoA thiolase Molybdenum cofactor A MOCS1 MOCS2 GPHN N- acetylaspartate NAT8L N- terminal acetyltransferase NAA10 Non- ketotic hyperglycinemia AMT Norum disease LCAT PEPCK, mitochondrial PCK2 PKU PAH Phosphoenolpyruvate carboxykinase- 1, cytosolic, PCK1 Phosphoglycerate dehydrogenase PHGDH Phosphoglycerate kinase 1 PGK1 Phosphoserine aminotransferase PSAT1 Phosphoserine phosphatase PSPH Prolidase PEPD Propionicacidemia PCCA PCCB Pyruvate dehydrogenase lipoic acid synthetase LIAS Riboflavin SLC52A1 Ribose 5- phosphate isomerase RPIA AICA- ribosiduria due to ATIC ATIC Rickets SLC34A3 DMP1 FGF23 ENPP1 PHEX VDR CYP2R1 CYP27B1 SBCAD ACADSB SCAD ACADS Succinic semialdehyde dehydrogenase ALDH5A1 Sucrase- isomaltase, congenital SI Sulfite oxidase SUOX Thiamine metabolism dysfunction 2 (biotin- or thiamine- responsive encephalopathy type 2) SLC19A3 Thiamine metabolism dysfunction 5 (episodic encephalopathy type) TPK1 Transaldolase TALDO1 transcobalamin receptor (TCBlR) (transcobalamin transport issue) CD320 Trifunctional protein HADHB Trimethylaminuria FMO3 Tumoral calcinosis, hyperphosphatemic, familial GALNT3 Tyrosinemia FAH TAT HPD Urea Cycle ARG1 ASL CPS1 ASS1 NAGS OTC Urocanase UROC1 VLCAD ACADVL Xanthinuria, type I XDH

Nuclear mitochondrial genes 3- Methylcrotonyl- CoA carboxylase 1 MCCC1 3- Methylcrotonyl- CoA carboxylase 2 MCCC2 3- methylglutaconic aciduria, type I AUH ACAD9 ACAD9 Acetyl- CoA carboxylase ACACA Acetyl- CoA carboxylase ACACB Argininemia ARG1 Autosomal Recessive Spastic Ataxia with Leukoencephalopathy MARS2 Barth TAZ Biotinidase BTD Carbamoylphosphate synthetase I CPS1 Carnitine, systemic primary Carnitine- acylcarnitine translocase SLC25A20 Charcot- Marie- Tooth disease, recessive intermediate, B KARS Citrullinemia, type II SLC25A13 Coenzyme Q10, primary, 1 COQ2 PDSS1 PDSS2 ADCK3 COQ9 Combined oxidative phosphorylation GFM1 MTO1 EARS2 FARS2 MTFMT ELAC2 MRPS16 TSFM TUFM MRPS22 C12orf65 AARS2 MRPL3 Congenital disorder of glycosylation MPI PMM2 CPT CPT1B CPT1A CPT2 cytochrome c oxidase SCO2 COX15 COX6B1 COX4I1 COX7A1 COX14 Dihydrolipoamide dehydrogenase DLD Ethylmalonic encephalopathy ETHE1 Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis COX4I2 Glutaric acidemia ETFA ETFB ETFDH Glycogen storage disease GYS1 G6PC SLC37A4 GAA AGL GBE1 PHKG2 PYGL PFKM PGAM2 PGM1 GYS2 PHKA2 PYGM PHKA1 PHKB Hepatic failure, early onset, and neurologic disorder SCO1 Holocarboxylase synthetase HLCS Homocystinuria- megaloblastic anemia, cbl E type MTRR Hyperornithinemia- hyperammonemia- homocitrullinemia SLC25A15 Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis SARS2 Isovaleric acidemia IVD Lacticacidemia due to PDX1 PDHX Leigh BCS1L NDUFA10 NDUFAF2 NDUFS4 NDUFS7 SDHA COX15 FOXRED1 NDUFA12 NDUFA2 NDUFA9 NDUFAF6 NDUFS3 NDUFS8 SURF1 LRPPRC PDHA1 Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation DARS2 Liver failure, transient infantile TRMU Methylmalonic aciduria MMACHC MMADHC LMBRD1 MUT MMAA MMAB Mitochondrial complex 1 NDUFAF5 FOXRED1 NDUFA1

NDUFA10 NDUFA11 NDUFAF1 NDUFAF3 NDUFB3 NDUFB9 NDUFS1 NDUFS2 NDUFS3 NDUFS4 NDUFS6 NDUFV1 NDUFV2 NUBPL Mitochondrial complex II SDHAF1 Mitochondrial complex III BCS1L TTC19 UQCRB UQCRQ Mitochondrial complex IV COA5 FASTKD2 TACO1 Mitochondrial complex V (ATP synthase) ATPAF2 TMEM70 ATP5E Mitochondrial DNA depletion TYMP AGK SLC25A4 TK2 DGUOK POLG SUCLA2 MPV17 C10orf2 RRM2B SUCLG1 Mitochondrial myopathy and sideroblastic anemia 1 PUS1 Mitochondrial phosphate carrier SLC25A3 Mohr- Tranebjaerg / Jensen TIMM8A Multiple mitochondrial dysfunctions NFU1 BOLA3 Myoglobinuria, acute recurrent, autosomal recessive LPIN1 Myopathy with lactic acidosis, hereditary ISCU Myopathy, lactic acidosis, and sideroblastic anemia 2 YARS2 N- acetylglutamate synthase NAGS Deafness, autosomal recessive 89 KARS Alpha- methylacetoacetic aciduria LCAD ACADL MCAD ACADM Optic atrophy OPA3 OPA1 Ornithine transcarbamylase OTC Paragangliomas SDHAF2 SDHC SDHB Perrault HARS2 LARS2 Pontocerebellar hypoplasia RARS2 Progressive external ophthalmoplegia SLC25A4 POLG2 RRM2B C10orf2 Propionicacidemia PCCB PCCA Pyruvate carboxylase PC Pyruvate dehydrogenase E1- alpha PDHA1 Pyruvate dehydrogenase E1- beta PDHB Pyruvate dehydrogenase E2 DLAT Pyruvate dehydrogenase phosphatase PDP1 Spastic paraplegia 55, autosomal recessive C12orf65 Thiamine metabolism dysfunction 4 SLC25A19 Transcobalamin II TCN2 Trifunctional protein HADHB Additional nuclear mitochondrial genes MRRF NARS2 NDUFA13 NDUFA4 NDUFA6 NDUFA7 NDUFA8 NDUFAF2 NDUFAF7 NDUFB1 NDUFB6 NDUFC2 NDUFS5 NDUFV3 TFAM TFB1M

Fatty acid oxidation Disorders CPT CPT1B CPT1A CPT2 ACAD9 ACAD9 ACADL ACADL Acyl- CoA dehydrogenase, medium chain, of ACADM Acyl- CoA dehydrogenase, short- chain, of ACADS Barth TAZ Carnitine, systemic primary Carnitine- acylcarnitine translocase SLC25A20 LCHAD / Trifunctional protein Myoglobinuria, acute recurrent, autosomal recessive LPIN1 Trifunctional protein HADHB VLCAD ACADVL Lysosomal disease Alpha Mannosidosis MAN2B1 Alpha NAGA NAGA Combined SAP Fabry disease GLA Free Sialic Acid Storage SLC17A5 Fucosidosis FUCA1 Gaucher GBA Gaucher disease, atypical GM1 gangliosidosis GLB1 GM2 gangliosidosis AB variant GM2A Hunter IDS Hurler IDUA I cell disease GNPTAB Krabbe GALC Krabbe disease, atypical Lysosomal Acid Lipase LIPA Mannosidosis, beta MANBA Maroteaux Lamy ARSB Metachromatic leukodystrophy ARSA Metachromatic leukodystrophy due to SAP- b Morquio A GALNS Mucopolysaccharidosis type IVB (Morquio) GLB1 Mucolipidosis IV MCOLN1 Mucopolysaccharidosis type IX HYAL1 Multiple sulfatase SUMF1 Niemann- Pick disease, type A/B SMPD1 Niemann- Pick disease, type C1, type D NPC1 Niemann- pick disease, type C2 NPC2 Mucopolysaccharidisis type IIIA (Sanfilippo A) SGSH Mucopolysaccharidosis type IIIB (Sanfilippo B) NAGLU Mucopolysaccharidosis type IIIC (Sanfilippo C) HGSNAT Mucopolysaccharidosis type IIID / San Filippo D GNS Sandhoff disease HEXB Sialidosis NEU1 Sly GUSB Tay Sachs HEXA